INTU vs JNJ: Which Is the Better Buy?
Side-by-side comparison of Intuit Inc. and Johnson & Johnson โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Intuit Inc. ยท Technology
$277.13
+25.3% upside to fair value
Med Conviction
Grade B
High Quality
VS
Johnson & Johnson ยท Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
INTU has more upside to fair value
(+25.3%).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
INTU |
JNJ |
| Current Price |
$277.13 |
$270.68 |
| Fair Value Estimate |
$347.25 |
$286.05 |
| Upside to Fair Value |
+25.3%
|
+5.7%
|
| Market Cap |
$75.8B |
$652.3B |
| Forward P/E |
โ
|
โ
|
| EV / EBITDA |
11.0x
|
20.2x
|
| Price / Sales |
3.5x
|
6.7x
|
| Price / FCF |
8.8x
|
35.3x
|
| Revenue Growth YoY |
+13.7%
|
+6.6%
|
| Gross Margin |
80.9%
|
67.9%
|
| Operating Margin |
28.8%
|
26.8%
|
| Return on Equity |
23.4%
|
25.7%
|
| Dividend Yield |
1.73% |
1.95% |
| FCF Yield |
11.43%
|
2.83%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
Intuit is a financial management software platform serving small and mid-market businesses through QuickBooks, consumers through TurboTax, and consumers through Credit Karma, with a professional tax segment in Lacerte, ProSeries and ProConnect. The business quality is high on fundamentals: TTM gross margin of 80.9%, TTM operating margin of 28.8%, TTM net margin of 21.3%, ROE of 23.4%, and free caโฆ
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:โฆ
Accumulation Zones
| Metric |
INTU |
JNJ |
| Zone Low |
$260.44 |
$214.54 |
| Zone High |
$295.16 |
$243.14 |
| In Buy Zone? |
Yes
|
No
|